Global Orally Disintegrating Tablet Excipient Market Growth 2021-2026

Global Orally Disintegrating Tablet Excipient Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orally Disintegrating Tablet Excipient Consumption 2016-2026
2.1.2 Orally Disintegrating Tablet Excipient Consumption CAGR by Region
2.2 Orally Disintegrating Tablet Excipient Segment by Type
2.2.1 Binders
2.2.2 Glidents
2.2.3 Diluents
2.2.4 Disintegrants
2.2.5 Others
2.3 Orally Disintegrating Tablet Excipient Sales by Type
2.3.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
2.3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2016-2021)
2.3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Type (2016-2021)
2.4 Orally Disintegrating Tablet Excipient Segment by Application
2.4.1 Anti-Psychotics Drug
2.4.2 Anti-Epileptics Drug
2.4.3 Others
2.5 Orally Disintegrating Tablet Excipient Sales by Application
2.5.1 Global Orally Disintegrating Tablet Excipient Sale Market Share by Application (2016-2021)
2.5.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Application (2016-2021)
2.5.3 Global Orally Disintegrating Tablet Excipient Sale Price by Application (2016-2021)

3 Global Orally Disintegrating Tablet Excipient by Company
3.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company
3.1.1 Global Orally Disintegrating Tablet Excipient Sales by Company (2019-2021)
3.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2019-2021)
3.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company
3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Company (2019-2021)
3.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2019-2021)
3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Company
3.4 Global Manufacturers Orally Disintegrating Tablet Excipient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orally Disintegrating Tablet Excipient Product Location Distribution
3.4.2 Players Orally Disintegrating Tablet Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Orally Disintegrating Tablet Excipient by Region
4.1 Global Orally Disintegrating Tablet Excipient by Region
4.1.1 Global Orally Disintegrating Tablet Excipient Sales by Region
4.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Region
4.2 Americas Orally Disintegrating Tablet Excipient Sales Growth
4.3 APAC Orally Disintegrating Tablet Excipient Sales Growth
4.4 Europe Orally Disintegrating Tablet Excipient Sales Growth
4.5 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Growth

5 Americas
5.1 Americas Orally Disintegrating Tablet Excipient Sales by Country
5.1.1 Americas Orally Disintegrating Tablet Excipient Sales by Country (2016-2021)
5.1.2 Americas Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021)
5.2 Americas Orally Disintegrating Tablet Excipient Sales by Type
5.3 Americas Orally Disintegrating Tablet Excipient Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Orally Disintegrating Tablet Excipient Sales by Region
6.1.1 APAC Orally Disintegrating Tablet Excipient Sales by Region (2016-2021)
6.1.2 APAC Orally Disintegrating Tablet Excipient Revenue by Region (2016-2021)
6.2 APAC Orally Disintegrating Tablet Excipient Sales by Type
6.3 APAC Orally Disintegrating Tablet Excipient Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Orally Disintegrating Tablet Excipient by Country
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2016-2021)
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021)
7.2 Europe Orally Disintegrating Tablet Excipient Sales by Type
7.3 Europe Orally Disintegrating Tablet Excipient Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Orally Disintegrating Tablet Excipient by Country
8.1.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Country (2016-2021)
8.1.2 Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021)
8.2 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Type
8.3 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Orally Disintegrating Tablet Excipient Distributors
10.3 Orally Disintegrating Tablet Excipient Customer

11 Global Orally Disintegrating Tablet Excipient Market Forecast
11.1 Global Orally Disintegrating Tablet Excipient Forecast by Region
11.1.1 Global Orally Disintegrating Tablet Excipient Forecast by Regions (2021-2026)
11.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Orally Disintegrating Tablet Excipient Forecast by Type
11.7 Global Orally Disintegrating Tablet Excipient Forecast by Application

12 Key Players Analysis
12.1 BASF
12.1.1 BASF Company Information
12.1.2 BASF Orally Disintegrating Tablet Excipient Product Offered
12.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 BASF Main Business Overview
12.1.5 BASF Latest Developments
12.2 JRS Pharma
12.2.1 JRS Pharma Company Information
12.2.2 JRS Pharma Orally Disintegrating Tablet Excipient Product Offered
12.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 JRS Pharma Main Business Overview
12.2.5 JRS Pharma Latest Developments
12.3 Roquette
12.3.1 Roquette Company Information
12.3.2 Roquette Orally Disintegrating Tablet Excipient Product Offered
12.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Roquette Main Business Overview
12.3.5 Roquette Latest Developments
12.4 ABF Ingredients
12.4.1 ABF Ingredients Company Information
12.4.2 ABF Ingredients Orally Disintegrating Tablet Excipient Product Offered
12.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 ABF Ingredients Main Business Overview
12.4.5 ABF Ingredients Latest Developments
12.5 DFE Pharma
12.5.1 DFE Pharma Company Information
12.5.2 DFE Pharma Orally Disintegrating Tablet Excipient Product Offered
12.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 DFE Pharma Main Business Overview
12.5.5 DFE Pharma Latest Developments
12.6 Evonik
12.6.1 Evonik Company Information
12.6.2 Evonik Orally Disintegrating Tablet Excipient Product Offered
12.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Evonik Main Business Overview
12.6.5 Evonik Latest Developments
12.7 Merck KGaA
12.7.1 Merck KGaA Company Information
12.7.2 Merck KGaA Orally Disintegrating Tablet Excipient Product Offered
12.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Merck KGaA Main Business Overview
12.7.5 Merck KGaA Latest Developments
12.8 Ashland
12.8.1 Ashland Company Information
12.8.2 Ashland Orally Disintegrating Tablet Excipient Product Offered
12.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Ashland Main Business Overview
12.8.5 Ashland Latest Developments
12.9 Meggle Pharma
12.9.1 Meggle Pharma Company Information
12.9.2 Meggle Pharma Orally Disintegrating Tablet Excipient Product Offered
12.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Meggle Pharma Main Business Overview
12.9.5 Meggle Pharma Latest Developments
12.10 Shin-Etsu
12.10.1 Shin-Etsu Company Information
12.10.2 Shin-Etsu Orally Disintegrating Tablet Excipient Product Offered
12.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Shin-Etsu Main Business Overview
12.10.5 Shin-Etsu Latest Developments
12.11 Fuji Chemical Industries
12.11.1 Fuji Chemical Industries Company Information
12.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Offered
12.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Fuji Chemical Industries Main Business Overview
12.11.5 Fuji Chemical Industries Latest Developments
12.12 McePharma (Vivesa holding)
12.12.1 McePharma (Vivesa holding) Company Information
12.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Offered
12.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 McePharma (Vivesa holding) Main Business Overview
12.12.5 McePharma (Vivesa holding) Latest Developments
12.13 Cargill Incorporated
12.13.1 Cargill Incorporated Company Information
12.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Offered
12.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Cargill Incorporated Main Business Overview
12.13.5 Cargill Incorporated Latest Developments
12.14 Daicel Corporation
12.14.1 Daicel Corporation Company Information
12.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Product Offered
12.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Daicel Corporation Main Business Overview
12.14.5 Daicel Corporation Latest Developments
12.15 Anhui Sunhere Pharmaceutical
12.15.1 Anhui Sunhere Pharmaceutical Company Information
12.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Offered
12.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Anhui Sunhere Pharmaceutical Main Business Overview
12.15.5 Anhui Sunhere Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Orally Disintegrating Tablet Excipient Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Binders
Table 3. Major Players of Glidents
Table 4. Major Players of Diluents
Table 5. Major Players of Disintegrants
Table 6. Major Players of Others
Table 7. Global Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 8. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 9. Global Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & ($ million)
Table 10. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2021)
Table 11. Global Orally Disintegrating Tablet Excipient Sale Price by Type (2016-2021)
Table 12. Global Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 13. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 14. Global Orally Disintegrating Tablet Excipient Value by Application (2016-2021)
Table 15. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2021)
Table 16. Global Orally Disintegrating Tablet Excipient Sale Price by Application (2016-2021)
Table 17. Global Orally Disintegrating Tablet Excipient Sales by Company (2019-2021) & (K MT)
Table 18. Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2019-2021)
Table 19. Global Orally Disintegrating Tablet Excipient Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2019-2021)
Table 21. Global Orally Disintegrating Tablet Excipient Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Orally Disintegrating Tablet Excipient Producing Area Distribution and Sales Area
Table 23. Players Orally Disintegrating Tablet Excipient Products Offered
Table 24. Orally Disintegrating Tablet Excipient Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Orally Disintegrating Tablet Excipient Sales by Region (2016-2021) (K MT)
Table 28. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2016-2021)
Table 29. Global Orally Disintegrating Tablet Excipient Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2016-2021)
Table 31. Americas Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
Table 32. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Country (2016-2021)
Table 33. Americas Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2016-2021)
Table 35. Americas Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 36. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 37. Americas Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 38. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 39. APAC Orally Disintegrating Tablet Excipient Sales by Region (2016-2021) & (K MT)
Table 40. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Region (2016-2021)
Table 41. APAC Orally Disintegrating Tablet Excipient Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2016-2021)
Table 43. APAC Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 44. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 45. APAC Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 46. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 47. Europe Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
Table 48. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2016-2021)
Table 49. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2016-2021)
Table 51. Europe Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 52. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 53. Europe Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 54. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
Table 56. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
Table 60. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
Table 62. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Orally Disintegrating Tablet Excipient
Table 64. Key Application and Potential Industries of Orally Disintegrating Tablet Excipient
Table 65. Key Challenges of Orally Disintegrating Tablet Excipient
Table 66. Key Trends of Orally Disintegrating Tablet Excipient
Table 67. Orally Disintegrating Tablet Excipient Distributors List
Table 68. Orally Disintegrating Tablet Excipient Customer List
Table 69. Global Orally Disintegrating Tablet Excipient Sales Forecast by Region (2021-2026) & (K MT)
Table 70. Global Orally Disintegrating Tablet Excipient Consumption Market Forecast by Region
Table 71. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) & (K MT)
Table 74. Americas Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Orally Disintegrating Tablet Excipient Sales Forecast by Region (2021-2026) & (K MT)
Table 76. APAC Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) & (K MT)
Table 78. Europe Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Forecast by Country (2021-2026) & (K MT)
Table 80. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2021-2026) & (K MT)
Table 82. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2021-2026) & (K MT)
Table 86. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Application (2021-2026)
Table 89. BASF Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 90. BASF Orally Disintegrating Tablet Excipient Product Offered
Table 91. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 92. BASF Main Business
Table 93. BASF Latest Developments
Table 94. JRS Pharma Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 95. JRS Pharma Orally Disintegrating Tablet Excipient Product Offered
Table 96. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 97. JRS Pharma Main Business
Table 98. JRS Pharma Latest Developments
Table 99. Roquette Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 100. Roquette Orally Disintegrating Tablet Excipient Product Offered
Table 101. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 102. Roquette Main Business
Table 103. Roquette Latest Developments
Table 104. ABF Ingredients Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 105. ABF Ingredients Orally Disintegrating Tablet Excipient Product Offered
Table 106. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 107. ABF Ingredients Main Business
Table 108. ABF Ingredients Latest Developments
Table 109. DFE Pharma Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 110. DFE Pharma Orally Disintegrating Tablet Excipient Product Offered
Table 111. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 112. DFE Pharma Main Business
Table 113. DFE Pharma Latest Developments
Table 114. Evonik Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 115. Evonik Orally Disintegrating Tablet Excipient Product Offered
Table 116. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 117. Evonik Main Business
Table 118. Evonik Latest Developments
Table 119. Merck KGaA Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 120. Merck KGaA Orally Disintegrating Tablet Excipient Product Offered
Table 121. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 122. Merck KGaA Main Business
Table 123. Merck KGaA Latest Developments
Table 124. Ashland Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 125. Ashland Orally Disintegrating Tablet Excipient Product Offered
Table 126. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 127. Ashland Main Business
Table 128. Ashland Latest Developments
Table 129. Meggle Pharma Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 130. Meggle Pharma Orally Disintegrating Tablet Excipient Product Offered
Table 131. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 132. Meggle Pharma Main Business
Table 133. Meggle Pharma Latest Developments
Table 134. Shin-Etsu Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 135. Shin-Etsu Orally Disintegrating Tablet Excipient Product Offered
Table 136. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 137. Shin-Etsu Main Business
Table 138. Shin-Etsu Latest Developments
Table 139. Fuji Chemical Industries Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 140. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Offered
Table 141. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 142. Fuji Chemical Industries Main Business
Table 143. Fuji Chemical Industries Latest Developments
Table 144. McePharma (Vivesa holding) Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 145. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Offered
Table 146. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 147. McePharma (Vivesa holding) Main Business
Table 148. McePharma (Vivesa holding) Latest Developments
Table 149. Cargill Incorporated Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 150. Cargill Incorporated Orally Disintegrating Tablet Excipient Product Offered
Table 151. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 152. Cargill Incorporated Main Business
Table 153. Cargill Incorporated Latest Developments
Table 154. Daicel Corporation Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 155. Daicel Corporation Orally Disintegrating Tablet Excipient Product Offered
Table 156. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 157. Daicel Corporation Main Business
Table 158. Daicel Corporation Latest Developments
Table 159. Anhui Sunhere Pharmaceutical Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 160. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Offered
Table 161. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 162. Anhui Sunhere Pharmaceutical Main Business
Table 163. Anhui Sunhere Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Orally Disintegrating Tablet Excipient
Figure 2. Orally Disintegrating Tablet Excipient Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orally Disintegrating Tablet Excipient Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Orally Disintegrating Tablet Excipient Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Orally Disintegrating Tablet Excipient Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Binders
Figure 10. Product Picture of Glidents
Figure 11. Product Picture of Diluents
Figure 12. Product Picture of Disintegrants
Figure 13. Product Picture of Others
Figure 14. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 15. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2021)
Figure 16. Orally Disintegrating Tablet Excipient Consumed in Anti-Psychotics Drug
Figure 17. Global Orally Disintegrating Tablet Excipient Market: Anti-Psychotics Drug (2016-2021) & (K MT)
Figure 18. Orally Disintegrating Tablet Excipient Consumed in Anti-Epileptics Drug
Figure 19. Global Orally Disintegrating Tablet Excipient Market: Anti-Epileptics Drug (2016-2021) & (K MT)
Figure 20. Orally Disintegrating Tablet Excipient Consumed in Others
Figure 21. Global Orally Disintegrating Tablet Excipient Market: Others (2016-2021) & (K MT)
Figure 22. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2021)
Figure 23. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application in 2020
Figure 24. Orally Disintegrating Tablet Excipient Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company in 2020
Figure 26. Global Orally Disintegrating Tablet Excipient Sales Market Share by Regions (2016-2021)
Figure 27. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region in 2020
Figure 28. Americas Orally Disintegrating Tablet Excipient Sales 2016-2021 (K MT)
Figure 29. Americas Orally Disintegrating Tablet Excipient Revenue 2016-2021 ($ Millions)
Figure 30. APAC Orally Disintegrating Tablet Excipient Sales 2016-2021 (K MT)
Figure 31. APAC Orally Disintegrating Tablet Excipient Revenue 2016-2021 ($ Millions)
Figure 32. Europe Orally Disintegrating Tablet Excipient Sales 2016-2021 (K MT)
Figure 33. Europe Orally Disintegrating Tablet Excipient Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Orally Disintegrating Tablet Excipient Sales 2016-2021 (K MT)
Figure 35. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue 2016-2021 ($ Millions)
Figure 36. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2020
Figure 37. Americas Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2020
Figure 38. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 39. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 40. United States Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Region in 2020
Figure 45. APAC Orally Disintegrating Tablet Excipient Revenue Market Share by Regions in 2020
Figure 46. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2020
Figure 47. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020
Figure 48. China Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Orally Disintegrating Tablet Excipient Revenue Growth 2016-2021 ($

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs